Chinese herbal supplement joins list of disavowed COVID-19 therapiesApprovals (China), China Food and Drug Administration, China National Medical Products Administration (NMPA), China's National Medical Products Administration, COVID-19 Therapeutic, COVID-19 Therapies, Forbes, Global Times, Herbal Medications, Herbal Remedies, National Healthcare Security Administration (NHSA) (China), Studies, The China Food and Drug AdministrationThe Chinese government halted the recommendation of an herbal supplement used as a traditional Chinese treatment for mild cases of COVID-19. Read more April 18, 2022/by BioSpace https://www.pharmalive.com/wp-content/uploads/2022/04/BioSpaceherbs.jpg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2022-04-18 12:04:032022-04-18 12:04:03Chinese herbal supplement joins list of disavowed COVID-19 therapies